FIELD: medicine; pharmacology.
SUBSTANCE: substance for dermatological medical products on the basis of a collagenase of a microbic parentage represents an ultrafiltrate allocated from a cultural liquid of Streptomyces lavendulae strain VKPM S-910 with collagenolytic activity of 1800-2500 KEA/ml and proteolytic activity of 120-200 PE/ml.
EFFECT: obtaining of biologically active ultrafiltrate with high collagenolytic and proteolytic activity for an effective utilisation as a part of various wound-healthing preparations and dermatology.
3 ex
Title | Year | Author | Number |
---|---|---|---|
BACTERIAL COLLAGENASE-BASE PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2166950C1 |
ENZYMATIC WOUND HEALING MEDICATION | 2011 |
|
RU2484811C2 |
METHOD FOR PRODUCING A COLLAGENOLYTIC ENZYME | 2020 |
|
RU2758788C1 |
MICROBIAL COLLAGENASE MAKEUP PREPARATION | 2007 |
|
RU2355383C2 |
COMPOUND-REAGENT FOR CLEANING SURFACE OF BIOLOGICAL MARINE GROWN | 0 |
|
SU1794795A1 |
METHOD OF PROTEOLYTIC ENZYMES PREPARATION USED FOR RAW HIDE WORKING | 0 |
|
SU1788010A1 |
METHOD OF COLLAGENASE PREPARING | 0 |
|
SU1822879A1 |
STRAIN OF ACTINOMYCETE STREPTOMYCES LAVENDULAE - A PRODUCER OF PROTEOLYTIC ENZYMES | 0 |
|
SU1735364A1 |
METHOD FOR PRODUCTION OF PROTHEOLYTIC REAGENT FOR STRUCTURAL PROTEIN HYDROLYSIS | 2003 |
|
RU2244741C1 |
STRAIN CLOSTRIDIUM HISTOLYTICUM - PRODUCER OF COLLAGENASE | 2018 |
|
RU2684220C1 |
Authors
Dates
2008-12-10—Published
2007-06-19—Filed